investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of TGF-beta antagonists for cancer therapy
Lalage Wakefield
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Peter Watson
BC Cancer Agency
Vancouver, Canada
Lalage Wakefield
National Cancer Institute (NIH)
Rockville, United States
Related projects
Rong Li
Regulation of Hormone Production by Matrix Proteins
Breast
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Breast
Roger D Kamm
Microfluidic 3D Assays for Metastatic Cancer
Breast
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Needs Assessment to Assess Barriers to Developing a Comprehensive Cancer Center in LMICs
Breast
Powel Brown
ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL
Breast
Powel Brown
VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast
Christopher Benz
Mass Spectrometry to Decode PTM Patterns and Enhance the Biomarker Utility of ER
Breast